Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Dalhoff

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Journal of Clinical Pharmacology|May 29, 2026
Hepatic CYP1A2 Activity in Adolescents with and without Obesity Assessed by the Urinary Paraxanthine-to-Caffeine Metabolic Ratio: A Pharmacokinetic StudyChristina Gade, Shahid Ullah, Kim Dalhoff, et al.
Ugeskrift for Laeger|December 15, 2020
[Local anaesthetic systemic toxicity]Karl Sebastian Johansson, Lotte Christine Groth Høgberg, Mikkel Bring Christensen, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 20, 2011
The role of the glutathione S-transferase genes GSTT1, GSTM1, and GSTP1 in acetaminophen-poisoned patientsAnders Buchard, Martin Eefsen, Synne Semb, et al.
Pharmacogenetics and Genomics|November 9, 2021
Background sensitivity to chemotherapy-induced nausea and vomiting and response to antiemetics in paediatric patients: a genetic association studyAstrid Eliasen, Jonatan Kornholt, René Mathiasen, et al.
European Journal of Epidemiology|May 21, 2025
Changes in LDL-cholesterol levels following aromatase inhibitor treatment in early postmenopausal breast cancerMarie Lund, Giulia Corn, Maj-Britt Jensen, et al.
The Lancet. Oncology|October 31, 2024
Ischaemic cardiotoxicity of aromatase inhibitors in postmenopausal patients with early breast cancer in Denmark: a cohort study of real-world dataMarie Lund, Giulia Corn, Maj-Britt Jensen, et al.
The Lancet. Oncology|February 6, 2025
Aromatase inhibitors, cardiovascular medications, and patient outcomes - Authors' replyMarie Lund, Giulia Corn, Maj-Britt Jensen, et al.
Blood|March 26, 2010
The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy numberJannie Gregers, Ib Jarle Christensen, Kim Dalhoff, et al.
Ugeskrift for Laeger|April 13, 2026
Kim Dalhoff, Tonny S Petersen, Søren Bøgevig, et al.
British Journal of Clinical Pharmacology|November 3, 2010
Methodological characteristics of academic clinical drug trials--a retrospective cohort study of applications to the Danish Medicines Agency 1993-2005Louise Berendt, Cecilia Håkansson, Karin F Bach, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Journal of Clinical Pharmacology|May 29, 2026
Hepatic CYP1A2 Activity in Adolescents with and without Obesity Assessed by the Urinary Paraxanthine-to-Caffeine Metabolic Ratio: A Pharmacokinetic StudyChristina Gade, Shahid Ullah, Kim Dalhoff, et al.
Ugeskrift for Laeger|December 15, 2020
[Local anaesthetic systemic toxicity]Karl Sebastian Johansson, Lotte Christine Groth Høgberg, Mikkel Bring Christensen, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 20, 2011
The role of the glutathione S-transferase genes GSTT1, GSTM1, and GSTP1 in acetaminophen-poisoned patientsAnders Buchard, Martin Eefsen, Synne Semb, et al.
Pharmacogenetics and Genomics|November 9, 2021
Background sensitivity to chemotherapy-induced nausea and vomiting and response to antiemetics in paediatric patients: a genetic association studyAstrid Eliasen, Jonatan Kornholt, René Mathiasen, et al.
European Journal of Epidemiology|May 21, 2025
Changes in LDL-cholesterol levels following aromatase inhibitor treatment in early postmenopausal breast cancerMarie Lund, Giulia Corn, Maj-Britt Jensen, et al.
The Lancet. Oncology|October 31, 2024
Ischaemic cardiotoxicity of aromatase inhibitors in postmenopausal patients with early breast cancer in Denmark: a cohort study of real-world dataMarie Lund, Giulia Corn, Maj-Britt Jensen, et al.
The Lancet. Oncology|February 6, 2025
Aromatase inhibitors, cardiovascular medications, and patient outcomes - Authors' replyMarie Lund, Giulia Corn, Maj-Britt Jensen, et al.
Blood|March 26, 2010
The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy numberJannie Gregers, Ib Jarle Christensen, Kim Dalhoff, et al.
Ugeskrift for Laeger|April 13, 2026
Kim Dalhoff, Tonny S Petersen, Søren Bøgevig, et al.
British Journal of Clinical Pharmacology|November 3, 2010
Methodological characteristics of academic clinical drug trials--a retrospective cohort study of applications to the Danish Medicines Agency 1993-2005Louise Berendt, Cecilia Håkansson, Karin F Bach, et al.
Pageof 10